The delisting move of Fresenius Kabi Oncology has raised eyebrows as only a few months back the company did a OFS.
SES Governance , a non profit Corporate Governance Research and Proxy Advisory firm has shared it’s analysis of the delisting.
[gview file=”https://alphaideas.in/wp-content/uploads/2013/04/SES-Fresenius-Kabi-Oncology-Research-April-20131.pdf”]